Ovarian Undifferentiated Carcinoma

general

An aggressive carcinoma arising from the ovary. Most patients present with advanced disease. Microscopically, it is characterized by significant cytologic atypia, increased mitotic activity, and necrosis. The prognosis is usually poor.

81

Centers

358

Active Trials

$1.4B

Cancer Funding

Specific Cancer Types(2)

Top Centers for Ovarian Undifferentiated Carcinoma(81)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
171.7
2
NCI Comprehensive
High-Volume Research Center
71.7
3
NCI Comprehensive
High-Volume Research Center
71.7
4
NCI Comprehensive
High-Volume Research Center
71.7
5
High-Volume Research Center
71.7
6
NCI Comprehensive
Active Research Program
61.5
7
NCI Comprehensive
Active Research Program
61.5
8
NCI Comprehensive
Active Research Program
61.5
9
NCI Comprehensive
Active Research Program
61.5
10
NCI Comprehensive
Active Research Program
61.5
11
NCI Comprehensive
Active Research Program
61.5
12
NCI Comprehensive
Active Research Program
61.5
13
NCI Comprehensive
Active Research Program
61.5
14
NCI Comprehensive
Active Research Program
61.5
15
NCI Comprehensive
Active Research Program
61.5
16
NCI Comprehensive
Active Research Program
61.5
17
NCI Comprehensive
Active Research Program
61.5
18
NCI Comprehensive
Active Research Program
61.5
19
NCI Comprehensive
Active Research Program
61.5
20
NCI Comprehensive
Active Research Program
61.5
21
Active Research Program
61.5
22
NCI Comprehensive
Active Research Program
61.5
23
Active Research Program
61.5
24
NCI Comprehensive
Active Research Program
61.5
25
NCI Clinical
Active Research Program
61.5
26
NCI Comprehensive
Active Research Program
61.5
27
NCI Comprehensive
Active Research Program
61.5
28
Active Research Program
61.5
29
Active Research Program
61.5
30
NCI Comprehensive
Active Research Program
61.5
3161.5
32
Active Research Program
61.5
33
Active Research Program
61.5
34
Active Research Program
61.5
35
Active Research Program
61.5
36
NCI Comprehensive
Active Research Program
48.0
37
NCI Comprehensive
Active Research Program
48.0
38
NCI Comprehensive
Active Research Program
48.0
39
NCI Comprehensive
Active Research Program
48.0
40
NCI Comprehensive
Active Research Program
48.0
41
NCI Comprehensive
Active Research Program
48.0
42
NCI Clinical
Active Research Program
48.0
43
Active Research Program
48.0
44
NCI Comprehensive
Active Research Program
48.0
45
NCI Clinical
Active Research Program
48.0
46
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
48.0
47
Active Research Program
48.0
48
Active Research Program
48.0
49
Active Research Program
48.0
50
Active Research Program
48.0
51
Active Research Program
48.0
52
NCI Comprehensive
Active Research Program
38.1
53
NCI Comprehensive
Active Research Program
38.1
54
NCI Comprehensive
Active Research Program
38.1
55
NCI Comprehensive
Active Research Program
38.1
56
NCI Comprehensive
Active Research Program
38.1
57
NCI Comprehensive
Active Research Program
38.1
58
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
38.1
59
NCI Clinical
Active Research Program
38.1
60
NCI Comprehensive
Active Research Program
38.1
61
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
38.1
62
NCI Comprehensive
Active Research Program
38.1
63
NCI Comprehensive
Active Research Program
38.1
64
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
38.1
65
Active Research Program
38.1
66
Active Research Program
38.1
67
Active Research Program
38.1
68
Active Research Program
38.1
69
Active Research Program
38.1
70
NCI Clinical
Contributing Research Center
31.1
71
NCI Basic_laboratory
Contributing Research Center
31.1
72
Contributing Research Center
31.1
73
Contributing Research Center
31.1
74
Contributing Research Center
31.1
75
BC CancerVancouver, BC
Contributing Research Center
31.1
76
NCI Comprehensive
28.7
7728.7
78
NCI Comprehensive
79
80
NCI Comprehensive
81

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →